Brief: Ssy Group Obtains China Approval For Ozagrel Sodium Injection
25/08/2026 11:17
BRIEF-Ssy Group Obtains China Approval For Ozagrel Sodium Injection Aug 25 (Reuters) - SSY Group Ltd 2005.HK:
SSY GROUP - OBTAINS CHINA APPROVAL FOR OZAGREL SODIUM INJECTION (5ML:40MG, 2.5ML:20MG)
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth